Publications
Detailed Information
Efficacy and safety of fluconazole prophylaxis in extremely low birth weight infants: multicenter pre-post cohort study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Juyoung | - |
dc.contributor.author | Kim, Han-Suk | - |
dc.contributor.author | Shin, Seung Han | - |
dc.contributor.author | Choi, Chang Won | - |
dc.contributor.author | Kim, Ee-Kyung | - |
dc.contributor.author | Choi, Eun Hwa | - |
dc.contributor.author | Kim, Beyong Il | - |
dc.contributor.author | Choi, Jung-Hwan | - |
dc.date.accessioned | 2017-02-10T00:50:09Z | - |
dc.date.available | 2017-03-16T16:34:24Z | - |
dc.date.issued | 2016-05-16 | - |
dc.identifier.citation | BMC Pediatrics, 16(1):67 | ko_KR |
dc.identifier.uri | https://hdl.handle.net/10371/100655 | - |
dc.description | This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. | ko_KR |
dc.description.abstract | Abstract
Background There have been many studies supporting fluconazole prophylaxis in preterm infants for prevention of invasive fungal infections (IFIs). However, the routine use of fluconazole prophylaxis in neonatal intensive care units (NICUs) raises concerns with respect to resistance development, including the selection of resistant Candida species. We aimed to evaluate the efficacy and safety of fluconazole prophylaxis in extremely low birth weight (ELBW) infants. Methods An interventional pre-post cohort study at two tertiary NICUs was conducted. Data from two 5-year periods with and without fluconazole prophylaxis (Mar 2008–Feb 2013 and Mar 2003–Feb 2008) was compared. Prophylactic fluconazole was administered starting on the 3rd day at a dose of 3mg/kg twice a week for 4weeks during the prophylaxis period. Results The fluconazole prophylaxis group consisted of 264 infants, and the non-prophylaxis group consisted of 159 infants. IFI occurred in a total of 19 neonates (4.7%) during the 10-year study period. Fluconazole prophylaxis lower the fungal colonization rate significantly (59.1% vs. 33.9%, P <0.001). However, the incidence of IFIs in ELBW infants was not reduced after fluconazole prophylaxis (4.4% vs. 5.5%, P = 0.80). Rather, although the increase did not reach statistical significance, fluconazole prophylaxis tended to increase the incidence of invasive infections involving fluconazole-resistant C. parapsilosis (0% vs. 41.7%, P = 0.11). Conclusions Fluconazole prophylaxis was not efficacious in decreasing IFIs in ELBW infants. There is a need for targeting prophylaxis to greatest risk population and prospective studies to measure the long-term effect of fluconazole prophylaxis on the emergence of organisms with antifungal resistance. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | BioMed Central | ko_KR |
dc.subject | Fluconazole | ko_KR |
dc.subject | Prophylaxis | ko_KR |
dc.subject | Invasive candidiasis | ko_KR |
dc.subject | Resistance | ko_KR |
dc.title | Efficacy and safety of fluconazole prophylaxis in extremely low birth weight infants: multicenter pre-post cohort study | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 이주영 | - |
dc.contributor.AlternativeAuthor | 김한석 | - |
dc.contributor.AlternativeAuthor | 신승한 | - |
dc.contributor.AlternativeAuthor | 최창원 | - |
dc.contributor.AlternativeAuthor | 김의경 | - |
dc.contributor.AlternativeAuthor | 최은화 | - |
dc.contributor.AlternativeAuthor | 김병일 | - |
dc.contributor.AlternativeAuthor | 최정환 | - |
dc.identifier.doi | 10.1186/s12887-016-0605-y | - |
dc.language.rfc3066 | en | - |
dc.rights.holder | Lee et al. | - |
dc.date.updated | 2017-01-06T10:22:49Z | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.